{
    "title": "Updating the Minimum Information about CLinical Artificial Intelligence (MI-CLAIM) checklist for generative modeling research",
    "abstract": "arXiv:2403.02558v1 Announce Type: new  Abstract: Recent advances in generative models, including large language models (LLMs), vision language models (VLMs), and diffusion models, have accelerated the field of natural language and image processing in medicine and marked a significant paradigm shift in how biomedical models can be developed and deployed. While these models are highly adaptable to new tasks, scaling and evaluating their usage presents new challenges not addressed in previous frameworks. In particular, the ability of these models to produce useful outputs with little to no specialized training data (\"zero-\" or \"few-shot\" approaches), as well as the open-ended nature of their outputs, necessitate the development of updated guidelines in using and evaluating these models. In response to gaps in standards and best practices for the development of clinical AI tools identified by US Executive Order 141103 and several emerging national networks for clinical AI evaluation, we be",
    "link": "https://arxiv.org/abs/2403.02558",
    "context": "Title: Updating the Minimum Information about CLinical Artificial Intelligence (MI-CLAIM) checklist for generative modeling research\nAbstract: arXiv:2403.02558v1 Announce Type: new  Abstract: Recent advances in generative models, including large language models (LLMs), vision language models (VLMs), and diffusion models, have accelerated the field of natural language and image processing in medicine and marked a significant paradigm shift in how biomedical models can be developed and deployed. While these models are highly adaptable to new tasks, scaling and evaluating their usage presents new challenges not addressed in previous frameworks. In particular, the ability of these models to produce useful outputs with little to no specialized training data (\"zero-\" or \"few-shot\" approaches), as well as the open-ended nature of their outputs, necessitate the development of updated guidelines in using and evaluating these models. In response to gaps in standards and best practices for the development of clinical AI tools identified by US Executive Order 141103 and several emerging national networks for clinical AI evaluation, we be",
    "path": "papers/24/03/2403.02558.json",
    "total_tokens": 855,
    "translated_title": "为生成建模研究更新有关临床人工智能（MI-CLAIM）检查表",
    "translated_abstract": "生成模型的最新进展，包括大型语言模型（LLMs）、视觉语言模型（VLMs）和扩散模型，加速了医学中自然语言和图像处理领域的发展，并标志着生物医学模型开发和部署方式的重大范式转变。尽管这些模型非常适应新任务，但在扩展和评估它们的使用过程中出现了前人框架未解决的新挑战。特别是，这些模型以少量或无需专门训练数据即可产生有用输出的能力（“零样本”或“少样本”方法），以及它们输出的开放性质，需要制定更新的使用和评估这些模型的指南。美国行政命令141103确定了有关临床人工智能工具开发的标准和最佳实践存在的差距，以及几个新兴国家临床人工智能评估网络。",
    "tldr": "生成模型的最新进展加速了医学中自然语言和图像处理领域的发展，并标志着生物医学模型开发和部署方式的重大范式转变。",
    "en_tdlr": "Recent advances in generative models have accelerated the field of natural language and image processing in medicine, marking a significant paradigm shift in how biomedical models can be developed and deployed."
}